IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tanigawa, M.
Right arrow Articles by Atherton, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tanigawa, M.
Right arrow Articles by Atherton, S. S.
(Investigative Ophthalmology and Visual Science. 2000;41:132-137.)
© 2000 by The Association for Research in Vision and Ophthalmology, Inc.

Natural Killer Cells Prevent Direct Anterior-to-Posterior Spread of Herpes Simplex Virus Type 1 in the Eye

Minoru Tanigawa1,3, John E. Bigger2, Maria Y. Kanter1 and Sally S. Atherton1,2

From the Departments of 1 Cellular and Structural Biology and 2 Microbiology, University of Texas Health Science Center at San Antonio; and the 3 Department of Ophthalmology, Kobe University School of Medicine, Japan.


   Abstract
Top
 Abstract
Introduction
 Methods
 Results
 Discussion
 References
 
PURPOSE. Anterior chamber (AC) inoculation of the KOS strain of herpes simplex virus type 1 (HSV-1) results in morphologic sparing of the ipsilateral retina, whereas the retina of the uninoculated contralateral eye becomes infected and undergoes acute retinal necrosis. Natural killer (NK) cells are an important component of the primary immune response to most virus infections. The purpose of this study was to determine whether NK cells are involved in preventing early direct anterior-to-posterior spread of HSV-1 after AC inoculation.

METHODS. Normal BALB/c mice were inoculated with 4 x 104 plaque-forming units (PFU) of the KOS strain of HSV-1 using the AC route. NK activity was measured in the spleen, the superficial cervical and submandibular lymph nodes, and the inoculated eye by lysis of chromium-labeled, NK-sensitive YAC-1 target cells. Histopathologic scoring and immunohistochemical staining for HSV-1 were performed in NK-depleted (injected intravenously with anti-asialo GM1) or mock-depleted (injected intravenously with normal rabbit serum) mice.

RESULTS. In mock-depleted mice, NK activity in the spleens, superficial cervical and submandibular lymph nodes, and inoculated eyes peaked at postinoculation (pi) day 5 and declined by pi day 7. Treatment with anti-asialo GM1 eliminated NK activity in the eye and at nonocular sites. The histopathologic scores at pi day 5 indicated more damage to the retinas of NK-depleted mice than to those of mock-depleted mice, and immunohistochemical staining for HSV-1 showed spread of the virus to the sensory retina only in NK-depleted mice.

CONCLUSIONS. NK cells were activated within 5 days after AC inoculation of the KOS strain of HSV-1. Activation of NK cells appears to play a role in preventing direct anterior-to-posterior spread of the virus in the inoculated eye which, in turn, protects the retina of this eye and helps to explain why the architecture of the retina of this eye is spared.


   Introduction
Top
 Abstract
 Introduction
Methods
 Results
 Discussion
 References
 
After uniocular anterior chamber (AC) inoculation of the KOS strain of herpes simplex virus (HSV)-1 in euthymic BALB/c mice, extensive virus infection accompanied by a massive inflammatory response is observed in the anterior segment of the injected eye.1 However, in spite of the virus infection and inflammation in the anterior segment, HSV-1 does not spread from the infected AC directly to the retina of the injected eye after uniocular AC inoculation.2 3 4 Although virus infection and retinitis are observed in the inoculated eye of T-cell–depleted mice, virus entering the retina of these mice spreads there through retrograde transport in the optic nerve of the injected eye on or about postinoculation (pi) day 9.5 Direct anterior-to-posterior spread of virus is not observed in T-cell–depleted mice at any time after inoculation. Thus, although T cells are involved in preventing spread of virus to the ipsilateral optic nerve,5 they do not appear to be responsible for preventing direct anterior-to-posterior spread of the KOS strain of HSV-1 after uniocular AC inoculation. Therefore, it is likely that a non–T-cell–dependent mechanism prevents spread of virus to the retina of the injected eye.

An early, but nonspecific, mechanism of protection operative in many types of infections is natural killer (NK) cells.6 NK cells, a subset of large, granular lymphocytes, are activated by the cytokines interferon (IFN)-{alpha}, IFN-ß, and interleukin (IL)-12 and can secrete cytokines with antiviral activity such as IFN-{gamma} and tumor necrosis factor (TNF)-{alpha} when activated.7 8 NK cells lyse virus-infected cells after conjugate recognition of those cells by a major histocompatibility complex–unrestricted mechanism. However, the eye constitutively expresses NK-suppressing factors, including TGF-ß and macrophage migration inhibitory factor, which have been shown to diminish NK activity in vitro.9 10 11 12 13 NK cells have been shown to be important in resistance to a number of primarily intracellular pathogens, including HSV. Intraperitoneal injection of HSV increases NK cell activity, and NK cells have been shown to modulate replication of HSV-1 in the liver and brain.14 15 16 The purpose of the studies described in this article was to examine the role of NK cells in the injected eye after uniocular AC inoculation of HSV-1. The results of these studies suggest that NK cells prevent direct anterior-to-posterior virus spread of KOS strain of HSV-1 in the injected eye after uniocular AC inoculation.


   Methods
Top
 Abstract
 Introduction
 Methods
Results
 Discussion
 References
 
Animals
Female BALB/c mice, 6 to 8 weeks old, were obtained from Taconic Farm (Germantown, NY). Animals were housed in accordance with National Institutes of Health guidelines. All animal experiments conformed to the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. Mice were maintained on a 12-hour light-dark cycle and given unrestricted access to food and water.

Virus
The KOS strain of HSV-1 was used in this study. Virus stocks were titered on Vero cell (ATCC, Rockville, MD) monolayers, as described previously.5

Ocular Injection
Mice were anesthetized by intramuscular injection of a cocktail containing 0.02 ml Rompun (X-JECT 5.A; Uetus Animal Health, St Joseph, MO) and 0.03 ml ketamine per 25 g body mass. The AC of the right eye of each mouse was inoculated with 4.0 x 104 plaque-forming units (PFU) of KOS in a volume of 2 µl.

Chromium Release Assay
One million YAC-1 target cells were labeled with 100 µCi chromium-51 (Du Pont–NEN, Wilmington, DE) for 1 hour in 500 µl RPMI 1640 with 5% fetal calf serum (RPMI-5) at 37°C. After labeling, the target cells were washed three times and seeded into 96-well plates at a concentration of 104 cells/100 µl per well. Effector cells were obtained from the spleen, the superficial cervical and submandibular lymph nodes, or the inoculated eye. Splenic effector cells were prepared by grinding the spleens between frosted slide glasses, followed by aspiration through a 22-gauge needle to make a single-cell suspension. Spleen cells were washed three times in Hanks’ balanced salt solution (HBSS), and erythrocytes were lysed by ammonium chloride treatment; the remaining spleen cells were washed three times in HBSS and resuspended in RPMI-5. Cells from the superficial cervical and submandibular lymph nodes ipsilateral to the site of injection were isolated by teasing the tissue through a 200-µm nylon mesh. The cells were then washed three times and resuspended in RPMI-5. Eyes were enucleated after cardiac perfusion, and the conjunctiva and extraocular muscles were removed under the dissecting microscope. The eyes were teased through a 70-µm mesh, and the cells were washed three times in HBSS and resuspended in RPMI-5. To have enough effector cells from the eye for the assays, three or four eyes were collected at each time point.

Splenocytes, lymph node cells, and ocular cells were counted, and 100 µl per well of the dilution of effector cells needed to give the appropriate effector-target ratio was plated in triplicate. For spontaneous release, 100 µl RPMI-5 and for maximum release, 100 µl 10% Triton X-100 (Sigma, St. Louis, MO) were added instead of effector cells. Plates were incubated for 4 hours at 37°C, and 100 µl of the supernatant in each well was counted in a gamma counter (Wizard 1470; Wallac, Turku, Finland). Each set of triplicates was averaged, and the percentage of specific lysis was determined by the following formula: % specific lysis = (experimental release - spontaneous release)/(maximum release - spontaneous release) x 100. Spontaneous release in all experiments was less than 10% of the maximum release.

Treatment of Mice with Anti-Asialo GM1 Serum
To deplete NK cell activity in vivo, a 10-fold dilution of anti-asialo GM1 rabbit serum (Wako Chemicals, Richmond, VA) was made in sterile phosphate-buffered saline (PBS) and injected into a tail vein in a volume of 0.1 ml. A single intravenous injection of this amount of anti-asialo GM1 reduced poly(I-C) activated splenic NK activity to undetectable levels for 4 days (not shown). This regimen had no effect on the splenic T-cell populations as determined by flow cytometry (not shown). Control animals were mock depleted with intravenous injections of the volume and concentration of normal rabbit serum (Vector Laboratories, Burlingame, CA). To maintain depletion of NK activity, anti-asialo GM1 serum was injected intravenously every 4 days beginning on day -1.

Histopathologic Evaluation of the Retina
Eyes were fixed in buffered formalin, embedded in paraffin, and sectioned. The sections were then stained with hematoxylin and eosin. A modification of the semiquantitative histopathologic scoring system described by Azumi and Atherton5 was used to evaluate the extent of retinal destruction, inflammatory cell infiltration, hypercellularity of the choroid, and amount of pyknotic debris as shown in Table 1 . The maximum possible histopathologic score for a single retina was 13.


View this table:
[in this window]
[in a new window]
  		Table 1. Histopathologic Evaluation of the Retina after Uniocular AC Inoculation of HSV-1

 
Immunohistochemistry
Mice were killed and perfused with PBS. The eyes were removed, embedded in Tissue-TEK O.C.T. (optimum cutting temperature) compound (Miles, Elkhart, IN), and sectioned at 8 µm using a cryostat. All sections were air dried and stored at -70°C. Before staining, sections were fixed in acetone for 5 minutes, washed twice with PBS, and placed in 0.3% hydrogen peroxide in methanol for 15 minutes. Sections were then washed twice with PBS and incubated with buffered casein solution (PowerBlock; Bio Genex, San Ramon, CA) for 15 minutes. Excess casein solution was blotted, and the sections were incubated with a 1:200 dilution of rabbit polyclonal anti-HSV-1 antibody (Dako, Carpinteria, CA) for 2 hours. The sections were washed twice with PBS, incubated with a 1:500 dilution of biotinylated goat anti-rabbit IgG (Vector) for 45 minutes, washed twice with PBS, and incubated with Vectastain ABC (Vector), according to the manufacturer’s directions. The sections then were washed three times with PBS and reacted with 0.5 mg/ml 3,3'-diaminobenzidine tetrahydrochloride solution (Sigma) supplemented with 0.3% nickel chloride and 0.01% hydrogen peroxide. Color development was monitored microscopically. All sections were counterstained with methyl green.


   Results
Top
 Abstract
 Introduction
 Methods
 Results
Discussion
 References
 
Activation of NK Cells in the Spleen, Lymph Nodes, and Eye after AC Inoculation of HSV-1
After AC inoculation of HSV-1 (KOS) into normal BALB/c mice, the ipsilateral retina does not become virus infected. Because there is no anatomic barrier to prevent virus spread within the eye and because T cells have been shown to protect the inoculated eye by preventing retrograde spread of virus from the brain,5 a non–T-cell mechanism, such as NK cells, appears to be responsible for preventing direct anterior-to-posterior spread of HSV-1 after uniocular AC inoculation. Injection of HSV-1 into the AC usually results in induction of anterior chamber–associated immune deviation (ACAID), and both the aqueous and the vitreous of the eye contain multiple substances that depress NK activity.9 10 11 12 13 To determine whether AC inoculation of HSV-1 induces an NK response, the cytolytic activity of cells from the spleen, lymph nodes, and inoculated eye was measured by chromium release assays. On day 1, 3, 5, or 7 before the chromium-release assay, 4.0 x 104 PFU of HSV-1 was injected into the AC of one eye. On the day of assay, mice were killed and cells from the spleen, lymph nodes, and inoculated eye were assayed for cytolytic activity against NK-sensitive YAC-1 target cells. As shown in Figure 1 , the cytolytic activity of splenocytes (Fig. 1A) , of cells from the superficial cervical and submandibular lymph nodes (Fig. 1B) , and of cells from the eye (Fig. 1C) was first detected on pi day 3, peaked on pi day 5, and returned to baseline on pi day 7. Treatment with anti-asialo GM1 eliminated NK activity of ocular cells (Fig. 2) and splenocytes (not shown).



View larger version (26K):
[in this window]
[in a new window]
  		Figure 1. Cytotoxicity of NK sensitive targets (YAC-1) by splenocytes (A), superficial cervical and submandibular lymph node cells (B), or ocular cells (C) after AC inoculation of HSV-1. Mice were infected using the AC route with 4.0 x 104 PFU of the KOS strain of HSV-1 on days 1, 3, 5, or 7 before assay. Splenocytes (A), superficial cervical and submandibular lymph node cells (B), or ocular cells (C) were harvested and single-cell suspensions were prepared and used in cytolytic assays against chromium-51–labeled YAC-1 targets. The results from one representative experiment of three experiments are shown.

 


View larger version (23K):
[in this window]
[in a new window]
  		Figure 2. Elimination of NK cytotoxic activity of ocular cells by treatment with anti-asialo GM1. Ocular cells were collected on pi day 5 from HSV-1–infected BALB/c mice treated with anti-asialo GM1 or from HSV-1–infected mice treated with an equivalent volume of normal rabbit serum. Ocular cells were also collected from normal uninfected mice. Single cell suspensions were prepared and used in cytolytic assays against chromium-51–labeled YAC-1 targets.

 
Destruction of the Ipsilateral Retina after Inoculation of KOS into the AC of NK-Depleted Mice
To determine whether the NK response after AC inoculation of KOS is involved in protecting the retina of the injected eye from viral infection and subsequent destruction, BALB/c mice were injected intravenously with anti-asialo GM1 serum or an equivalent volume and concentration of normal rabbit serum (control mice) on day -1; on day 0, 4.0 x 104 PFU of the KOS strain of HSV-1 was injected into the AC of one eye. Histopathologic scores of the inoculated eyes of NK-depleted mice were compared with those of the mock-depleted mice. At pi day 3, the retinas of mice in both groups had only slight atypical retinopathy, and there was no significant difference between the retinal scores of NK-depleted and mock-depleted control mice (not shown). However, by pi day 5, significantly more disease was observed in the retinas of NK-depleted mice than in the retinas of mock-depleted mice at pi day 5 (P < 0.035; Table 2 ). As shown in Figure 3 , destruction of the sensory retina, inflammatory cell infiltration, and choroidal hypercellularity were observed in retinas of mice in the NK-depleted group (Fig. 3B) , whereas in the mock-depleted mice, only mild retinal folding similar to that previously observed in the inoculated eyes of normal mice after AC injection of HSV-1 was seen (Fig. 3A) .1 5


View this table:
[in this window]
[in a new window]
  		Table 2. NK Depletion Increases Retinal Damage after AC Inoculation of HSV-1

 


View larger version (64K):
[in this window]
[in a new window]
  		Figure 3. NK depletion results in destruction of the retina of the injected eye. Photomicrographs of retinal sections of (A) mock-depleted (histopathologic score: 1) or (B) NK-depleted (histopathologic score: 7) mice 5 days after AC inoculation with HSV-1. Hematoxylin and eosin; original magnification, x70.

 
Spread of HSV-1 to the Posterior Segment in NK-Depleted Mice
To determine whether NK cells protect the inoculated eye from direct spread of HSV-1 to the posterior segment after AC injection, immunohistochemical staining for HSV-1 was performed on ocular sections from NK-depleted mice and mock-depleted mice. For these studies, mice were injected intravenously with anti-asialo GM1 serum on day -1 and injected with 4.0 x 104 PFU of KOS through the AC route on day 0. To verify the specificity of the anti-HSV-1 antibody, adjacent sections were incubated with normal rabbit serum and processed identically with the sections treated with anti-HSV-1 antibody. These control slides showed no reactivity (not shown). At day 3 pi, HSV-1–positive cells were observed in the choroid in both NK-depleted mice and mock-depleted mice (not shown). HSV-1–positive cells were not observed in the sensory retina of mice in either group at this time. However, at day 5 pi, HSV-1–positive cells were observed in the sensory retina, but not in the RPE or choroid, of NK-depleted mice (Figs. 4B 4D ). In contrast, HSV-1–postive cells were not observed in the retina, choroid, or RPE of the mock-depleted mice at pi day 5 (Figs. 4A 4C) .



View larger version (160K):
[in this window]
[in a new window]
  		Figure 4. NK depletion allows virus infection of the ipsilateral retina after AC inoculation. Photomicrographs of retinal sections from infected, mock-depleted (A and C), or infected, NK-depleted (B and D) mice 5 days after inoculation of 4 x 104 PFU of the KOS strain of HSV-1 through the AC route. Immunohistochemistry was conducted using anti-HSV-1 serum. Arrows: virus-infected cells in the sensory retina. Original magnification, x70 (A, C) and x280 (B, D).

 

   Discussion
Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
References
 
After uniocular AC inoculation of the KOS strain of HSV-1 in BALB/c mice, acute retinal necrosis is observed in the uninoculated contralateral eye, whereas the retina of the ipsilateral eye is spared from virus infection and destruction.1 2 3 4 The mechanism that prevents virus from spreading to the retina of the injected eye has been puzzling. It is known that this mechanism cannot be T-cell–mediated, because in T-cell–depleted mice, virus does not spread directly from the infected anterior segment to the retina. Even though bilateral retinitis develops in T-cell–depleted mice, retinitis in the injected eye of T-cell–depleted mice results from late (on or after pi day 9) spread of virus from the suprachiasmatic nucleus contralateral to the side of inoculation to the optic nerve of the injected eye and not from direct anterior-to-posterior spread of the virus.2 4 5

In the normal eye, immune privilege is maintained and inflammatory damage is prevented by immunosuppressive cytokines, such as TGF-ß and macrophage migration inhibitory factor, that are produced within the eye. However, these immunosuppressive ocular cytokines, which have also been shown to suppress NK activity,9 10 11 12 13 do not prevent induction of an NK response after uniocular AC inoculation of the KOS strain of HSV-1. The results from the studies presented in this article demonstrate that after uniocular AC inoculation of the KOS strain of HSV-1, there is both a local (eye and superficial cervical and submandibular lymph nodes) and a systemic (spleen) NK response, shown by cytolytic activity of mononuclear cells isolated from these sites against NK-sensitive YAC-1 targets. The reason ocular factors that normally suppress NK activity do not inhibit NK activation after AC inoculation of HSV-1 may be that the extensive virus replication and inflammation that occur within 1 to 2 days after AC inoculation1 17 outstrip the eye’s ability to produce these factors.

However, merely determining that AC inoculation of HSV-1 induces both a local and a systemic NK response does not provide information about the role of such a response during ocular infection or about how NK cells limit virus spread in the injected eye. Results from the immunohistochemistry and histopathologic studies suggest that depletion of NK cells allowed HSV-1 to spread to the ipsilateral retina early after infection and that subsequent virus replication in the retina led to increased retinal damage in NK-depleted mice. Interestingly, virus was observed at pi day 3 in the choroid, but not in the sensory retina, in both NK-depleted mice and mock-depleted mice. In both groups of mice, no virus-infected cells were detected in the choroid or RPE at pi day 5. However, at pi day 5, the retinas of NK-depleted mice had more histopathologic changes than the retinas of non-NK-depleted mice, and the retinal changes were observed coincident with virus infection of the retina. This observation suggests that after AC inoculation of HSV-1, the virus is able to spread to the choroid irrespective of the presence or absence of NK cells. However, NK cells or their products eliminate HSV-1 from the choroid of normal mice by pi day 5, and in so doing, protect the retina of the injected eye from virus infection and destruction.

There is a paucity of information about how NK cells or their products limit virus spread and replication within the eye. NK cells have been reported in the anterior segment (iris and corneal limbus) 5 days after AC inoculation of HSV-1 in BALB/c mice.18 Recently, NK cells have been shown to modulate retinal destruction in a mouse model of cytomegalovirus retinitis.19 It is not clear whether these cells are normally present within the eye and are activated by virus infection within the ocular compartment, whether these cells are activated at an extraocular site and migrate to the eye, or whether there are both ocular and extraocular populations of such cells.

In summary, the results presented in this article support the idea that NK cells are activated after uniocular AC inoculation of the KOS strain of HSV-1 and that these cells are important in preventing spread of this virus from the infected AC to the retina of the inoculated eye. Additional studies will be required, however, to determine the mechanism by which such cells prevent virus spread and the origin and site of activation of these cells.


   Footnotes
 
Supported by Fight for Sight, research division of Prevent Blindness America Postdoctoral Fellowship PD98015 (MT), and National Institutes of Health Grant EY06012 (SSA).

Submitted for publication April 20, 1999; revised August 27, 1999; accepted September 9, 1999.

Commercial relationships policy: N.

Corresponding author: Sally S. Atherton, Department of Cellular and Structural Biology, Mail Code 7762, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900. atherton{at}uthscsa.edu


   References
Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 

  1. Whittum, JA, McCulley, JP, Niederkorn, JY, Streilein, JW (1984) Ocular disease induced in mice by anterior chamber inoculation of herpes simplex virus Invest Ophthalmol Vis Sci 25,1065-1073[Abstract/Free Full Text]
  2. Whittum, JA, Pepose, JA (1987) Immunologic modulation of virus-induced pathology in a murine model of acute herpetic retinal necrosis Invest Ophthalmol Vis Sci 28,1541-1548[Abstract/Free Full Text]
  3. Margolis, TP, LaVail, JH, Setzer, PY, Dawson, CR. (1989) Selective spread of herpes simplex virus in the central nervous system after ocular inoculation J Virol 63,4756-4761[Abstract/Free Full Text]
  4. Vann, VR, Atherton, SS (1990) Neural spread of herpes simplex virus after anterior chamber inoculation Invest Ophthalmol Vis Sci 32,2462-2472[Abstract/Free Full Text]
  5. Azumi, A, Atherton, SS (1994) Sparing of the ipsilateral retina after anterior chamber inoculation of HSV-1: requirement for either CD4+ or CD8+ T cells Invest Ophthalmol Vis Sci 35,3251-3259[Abstract/Free Full Text]
  6. Gumperz, JE, Parham, P. (1995) The enigma of NK cells Nature 378,245-248[Medline][Order article via Infotrieve]
  7. Orange, JS, Wang, B, Terhorst, C, Biron, CA (1995) Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration J Exp Med 182,1045-1056[Abstract/Free Full Text]
  8. Welsh, RM, Brubaker, JO, Vargas–Cortes, MM, O’Donnell, CL (1991) Natural killer (NK) cell response to virus infections in mice with severe combined immunodeficiency. The stimulation of NK cells and the NK cell-dependent control of virus infection occur independently of T and B cell function J Exp Med 173,1053-1063[Abstract/Free Full Text]
  9. Jampel, HD, Roche, N, Stark, WJ, Roberts, AB (1990) Transforming growth factor-ß in human aqueous humor Curr Eye Res 9,963-969[Medline][Order article via Infotrieve]
  10. Cousins, SW, McCabe, MM, Danielpour, D, Streilein, J. (1991) Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor Invest Ophthalmol Vis Sci 32,2201-2211[Abstract/Free Full Text]
  11. Cousins, SW, Trattler, B, Streilein, JW (1991) Immune privilege and suppression of immunogenic inflammation in the anterior chamber of the eye Curr Eye Res 10,287-297[Medline][Order article via Infotrieve]
  12. Apte, RS, Niederkorn, JY (1996) Isolation and characterization of a unique natural killer cell inhibitory factor present in the anterior chamber of the eye J Immunol 156,2667-2673[Abstract]
  13. Apte, RS, Sinha, D, Mayhew, E, Wistow, GJ, Niederkorn, JY (1998) Role of macrophage inhibitory factor in inhibiting NK cell activity and preserving immune privilege J Immunol 160,5693-5696[Abstract/Free Full Text]
  14. Bukowski, JF, Welsh, RM (1986) The role of natural killer cells and interferon in resistance to acute infection of mice with herpes simplex virus type 1 J Immunol 136,3481-3485[Abstract]
  15. Rager–Zisman, B, Quan, PC, Rosner, M, Moller, JR, Bloom, BR (1987) Role of NK cells in protection of mice against herpes simplex virus-1 infection J Immunol 138,884-888[Abstract]
  16. Brandt, CR, Salkowski, CA (1992) Activation of NK cells in mice following corneal infection with herpes simplex virus type-1 Invest Ophthalmol Vis Sci 3,113-120
  17. Atherton, SS, Streilein, JW (1987) Two waves of virus following anterior chamber inoculation of HSV-1 Invest Ophthalmol Vis Sci 28,571-579[Abstract/Free Full Text]
  18. Young, LH, Foster, CS, Young, JD (1990) In vivo expression of perforin by natural killer cells during a viral infection. Studies on uveitis produced by herpes simplex virus type I Am J Pathol 136,1021-1030[Abstract]
  19. Bigger, JE, Thomas, CA, Atherton, SS (1998) NK cell modulation of murine cytomegalovirus retinitis J Immunol 160,5826-5831[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 IOVSHome page
M. Zheng, M. A. Fields, Y. Liu, H. Cathcart, E. Richter, and S. S. Atherton
Neutrophils Protect the Retina of the Injected Eye from Infection after Anterior Chamber Inoculation of HSV-1 in BALB/c Mice
Invest. Ophthalmol. Vis. Sci., September 1, 2008; 49(9): 4018 - 4025.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. A. Kittan, A. Bergua, S. Haupt, N. Donhauser, P. Schuster, K. Korn, T. Harrer, and B. Schmidt
Impaired Plasmacytoid Dendritic Cell Innate Immune Responses in Patients with Herpes Virus-Associated Acute Retinal Necrosis
J. Immunol., September 15, 2007; 179(6): 4219 - 4230.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
E. J. Shillitoe and C. Pellenz
Factors That Limit the Effectiveness of Herpes Simplex Virus Type 1 for Treatment of Oral Cancer in Mice
Clin. Cancer Res., April 15, 2005; 11(8): 3109 - 3116.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
D. J. J. Carr, J. Chodosh, J. Ash, and T. E. Lane
Effect of Anti-CXCL10 Monoclonal Antibody on Herpes Simplex Virus Type 1 Keratitis and Retinal Infection
J. Virol., September 15, 2003; 77(18): 10037 - 10046.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
N. M. Archin, L. van den Boom, L. Perelygina, J. M. Hilliard, and S. S. Atherton
Delayed Spread and Reduction in Virus Titer after Anterior Chamber Inoculation of a Recombinant of HSV-1 Expressing IL-16
Invest. Ophthalmol. Vis. Sci., July 1, 2003; 44(7): 3066 - 3076.
[Abstract] [Full Text] [PDF]

Home page
 J Med MicrobiolHome page
M. Zhu, X. Xu, H. Liu, X. Liu, S. Wang, F. Dong, B. Yang, and G. Song
Enhancement of DNA vaccine potency against herpes simplex virus 1 by co-administration of an interleukin-18 expression plasmid as a genetic adjuvant
J. Med. Microbiol., March 1, 2003; 52(3): 223 - 228.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. Grubor-Bauk, A. Simmons, G. Mayrhofer, and P. G. Speck
Impaired Clearance of Herpes Simplex Virus Type 1 From Mice Lacking CD1d or NKT Cells Expressing the Semivariant V{alpha}14-J{alpha}281 TCR
J. Immunol., February 1, 2003; 170(3): 1430 - 1434.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
R. B. Pyles, D. Higgins, C. Chalk, A. Zalar, J. Eiden, C. Brown, G. Van Nest, and L. R. Stanberry
Use of Immunostimulatory Sequence-Containing Oligonucleotides as Topical Therapy for Genital Herpes Simplex Virus Type 2 Infection
J. Virol., October 11, 2002; 76(22): 11387 - 11396.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
K. H. Edelmann and C. B. Wilson
Role of CD28/CD80-86 and CD40/CD154 Costimulatory Interactions in Host Defense to Primary Herpes Simplex Virus Infection
J. Virol., January 15, 2001; 75(2): 612 - 621.
[Abstract] [Full Text]

Home page
 J. Virol.Home page
M. Franchini, C. Abril, C. Schwerdel, C. Ruedl, M. Ackermann, and M. Suter
Protective T-Cell-Based Immunity Induced in Neonatal Mice by a Single Replicative Cycle of Herpes Simplex Virus
J. Virol., January 1, 2001; 75(1): 83 - 89.
[Abstract] [Full Text]

Home page
 JEMHome page
A. A. Nash
T Cells and the Regulation of Herpes Simplex Virus Latency and Reactivation
J. Exp. Med., April 24, 2000; 191(9): 1455 - 1458.
[Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tanigawa, M.
Right arrow Articles by Atherton, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tanigawa, M.
Right arrow Articles by Atherton, S. S.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS